Your browser doesn't support javascript.
loading
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.
Cortellini, Alessio; Chiari, Rita; Ricciuti, Biagio; Metro, Giulio; Perrone, Fabiana; Tiseo, Marcello; Bersanelli, Melissa; Bordi, Paola; Santini, Daniele; Giusti, Raffaele; Grassadonia, Antonino; Di Marino, Pietro; Tinari, Nicola; De Tursi, Michele; Zoratto, Federica; Veltri, Enzo; Malorgio, Francesco; Garufi, Carlo; Russano, Marco; Anesi, Cecilia; Zeppola, Tea; Filetti, Marco; Marchetti, Paolo; Berardi, Rossana; Rinaldi, Silvia; Tudini, Marianna; Silva, Rosa Rita; Pireddu, Annagrazia; Atzori, Francesco; Iacono, Daniela; Migliorino, Maria Rita; Porzio, Giampiero; Cannita, Katia; Ficorella, Corrado; Buti, Sebastiano.
Affiliation
  • Cortellini A; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. Electronic address: alessiocortellini@gmail.com.
  • Chiari R; Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy.
  • Ricciuti B; Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy.
  • Metro G; Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy.
  • Perrone F; Medical Oncology, University Hospital of Parma, Parma, Italy.
  • Tiseo M; Medical Oncology, University Hospital of Parma, Parma, Italy.
  • Bersanelli M; Medical Oncology, University Hospital of Parma, Parma, Italy.
  • Bordi P; Medical Oncology, University Hospital of Parma, Parma, Italy.
  • Santini D; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Giusti R; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Grassadonia A; Department of Medical, Oral & Biotechnological Sciences University G. D'Annunzio, Chieti-Pescara, Italy.
  • Di Marino P; Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, Italy.
  • Tinari N; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • De Tursi M; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Zoratto F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy.
  • Veltri E; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy.
  • Malorgio F; Medical Oncology, "Santo Spirito" Hospital, Pescara, Italy.
  • Garufi C; Medical Oncology, "Santo Spirito" Hospital, Pescara, Italy.
  • Russano M; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Anesi C; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Zeppola T; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Filetti M; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Marchetti P; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Berardi R; Oncology Clinic, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy.
  • Rinaldi S; Oncology Clinic, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy.
  • Tudini M; Medical Oncology, AV2 Fabriano ASUR Marche, Italy.
  • Silva RR; Medical Oncology, AV2 Fabriano ASUR Marche, Italy.
  • Pireddu A; Medical Oncology Unit, University Hospital of Cagliari, Cagliari, Italy.
  • Atzori F; Medical Oncology Unit, University Hospital of Cagliari, Cagliari, Italy.
  • Iacono D; Pulmonary Oncology Unit, St. Camillo-Forlanini Hospital, Rome, Italy.
  • Migliorino MR; Pulmonary Oncology Unit, St. Camillo-Forlanini Hospital, Rome, Italy.
  • Porzio G; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Cannita K; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Ficorella C; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Buti S; Medical Oncology, University Hospital of Parma, Parma, Italy.
Clin Lung Cancer ; 20(4): 237-247.e1, 2019 07.
Article in En | MEDLINE | ID: mdl-30885550
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Drug-Related Side Effects and Adverse Reactions / Antibodies, Monoclonal, Humanized / Nivolumab / Immune System Diseases / Immunotherapy / Lung Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2019 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Drug-Related Side Effects and Adverse Reactions / Antibodies, Monoclonal, Humanized / Nivolumab / Immune System Diseases / Immunotherapy / Lung Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2019 Document type: Article Country of publication: United States